Background: There is a significant demand for colorectal cancer (CRC) screening 19 methods that are noninvasive, inexpensive, and capable of accurately detecting early 20 stage tumors. It has been shown that models based on the gut microbiota can 21 complement the fecal occult blood test and fecal immunochemical test (FIT). However, 22 a barrier to microbiota-based screening is the need to collect and store a patient's stool 23
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Although colorectal cancer (CRC) mortality has declined in recent decades, it remains 43 the second leading cause of death among cancers in the United States [1] . Early 44 detection of CRC is critical since patients whose tumors are detected at an early stage 45 have a greater than 90% chance of survival [1] . However more than a third of 46 individuals for whom screening is recommended do not adhere to screening guidelines 47 [2] . The high cost and invasive nature of procedures, such as colonoscopy and 48 sigmoidoscopy are barriers for many people [3, 4] . Unfortunately non-invasive tests, 49 such as the guaiac fecal occult blood test (gFOBT), fecal immunochemical test (FIT), 50 and the multitarget DNA test fail to reliably detect adenomas [5, 6] (e.g., sensitivity for 51 nonadvanced adenomas is 7.6% for FIT and 17.2% for the DNA test). Thus, there is a 52 need for novel non-invasive screening methods with improved sensitivity for early stage 53 colonic lesions. 54
Several studies have demonstrated the potential for the gut microbiota to be used to 55 detect CRC [7-10]. Moreover, we and others have shown that combining microbiota-56 analysis with conventional diagnostics, like gFOBT and FIT, can significantly improve 57 the detection of colonic lesions over either method by itself [7, 8, 10]. One limitation of 58 microbiota-based CRC screening is the need to collect and process separate stool 59 samples for microbiota characterization. Given the widespread use of FIT to collect 60 specimens for screening, the ability to use the same sample for microbiota 61 characterization could make processing more efficient and less expensive. We 62 4 hypothesized that the small amount of fecal material contained in FIT sampling 63 cartridges was sufficient to perform both hemoglobin quantification and microbiota 64 characterization. To test this hypothesis, we isolated bacterial DNA from the residual 65 buffer of OC-Auto® FIT cartridges (Polymedco Inc.) that had already been used for 66 quantifying fecal hemoglobin concentrations. We then compared the bacterial 67 composition of the FIT cartridge to that of DNA isolated directly from a patient's stool 68 sample and assessed the ability of FIT cartridge-derived DNA to be used for microbiota-69 based CRC screening. 70 lesions. First, we tested whether the bacterial community profiles from FIT cartridges 115 recapitulated their stool counterparts. First, we compared the number of OTUs shared 116 within FIT/stool pairs from the same patient to the number of OTUs shared between 117 patients (Fig. 1A) . FIT cartridges and stool from the same patient (red line) had 118 significantly more bacterial populations in common than those taken from different 119 patients (p<0.001, two-sample Kolmogorov-Smirnov test), indicating that community 120 membership was conserved within patients across stool and FIT cartridges. Second, we 121 calculated the similarity in community structure between samples using 1-thetaYC index 122
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[17]. This metric compares the presence or absence of bacterial populations and their 123 relative abundance. The bacterial community structure of stool and FIT samples from 124 the same patient (red line) were significantly more similar to each other than to stool or 125 FIT from other patients (Fig. 1B, p<0 .001). Finally, we used a Mantel test to determine 126 whether the patient-to-patient thetaYC distances among stool samples were correlated 127 with the patient-to-patient thetaYC distances among FIT cartridges. We found that there 128 was a significant correlation (Mantel test r=0.525, p<0.001), suggesting that the inter-129 patient variation in community structure between the stool samples of patients was 130 conserved in samples from FIT cartridges. 131 7 Next, we observed a significant correlation between the abundance of each genus in 132 the paired FIT cartridge and stool samples ( Fig. 2A , Spearman rho: 0.699, p<0.001). 133
This suggested that the abundance of bacterial genera was conserved. This correlation 134 was especially strong when comparing only the 100 most abundant genera from stool 135 (Spearman rho: 0.886, p<0.001). Several bacterial species have been repeatedly 136 associated with CRC, including Fusobacterium nucleatum, Porphyromonas 137 asaccharolytica, Peptostreptococcus stomatis, and Parvimonas micra [8-10, 18]. As 138 expected, the abundance of these species in stool was significantly correlated with their 139 abundance in matched FIT cartridges (all p<0.001, Spearman rho ≥0.352)( Fig. 2B) . We 140 observed some biases in the abundance of certain taxa. In particular, the genus 141
Pantoea was detected in 399 of the 404 FIT cartridges with an average abundance of 142 2.4%, but was only detected in 1 stool sample. The genus Helicobacter was detected in 143 172 FIT cartridges, but only 10 stool samples. Likewise several genera of Actinobacteria 144 were more abundant in stool samples compared to FIT. Notwithstanding these few 145 exceptions, the abundance of the vast majority of genera were well conserved between 146 stool and FIT cartridges. Overall, these findings suggested that that the overall bacterial 147 community structure and the abundance of specific taxa in FIT cartridges and stool 148
were similar. 149
We tested whether the bacterial relative abundances we observed from FIT cartridges 150 could be used to differentiate healthy patients from those with carcinomas using random 151 forest models as we did previously using intact stool samples [10] . Using DNA from the 152 FIT cartridge, the optimal model utilized 28 OTUs and had an AUC of 0.831 (Fig. 3A) . 153
There was not a significant difference in the AUC for this model and the model based on 154 8 DNA isolated directly from stool, which used 32 OTUs and had an AUC of 0.853 155 (p=0.41). Furthermore, the probabilities of individuals having lesions were correlated 156 between the models generated using DNA isolated from the FIT cartridges and stool 157 samples (Spearman rho: 0.633, p<0.001, Fig. 3B ). We also generated random forest 158 models for differentiating healthy patients from those with any type of lesions (i.e. 159 adenoma or carcinoma). There was not a significant difference in AUC between the 160 stool-based model with 41 OTUs (AUC=0.700) and the FIT cartridge-based model with 161 41 OTUs (AUC=0.686, p=0.65, Fig. 3C ). Again, the probabilities of individuals having 162 lesions according to the two models were significantly correlated (Spearman rho: 0.389, 163 p<0.001 Fig. 3D ). These findings demonstrated that models based on bacterial DNA 164 from FIT cartridges were as predictive as models based on DNA isolated directly from 165 stool. 166
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Bacterial DNA isolated from the residual buffer of FIT cartridges recapitulated the 168 community structure and membership of patients' stool microbiota. FIT/stool pairs 169 collected from the same patient were significantly more similar to each other than 170 samples from different patients and the inter-patient differences in stool microbiota 171 structure were conserved in FIT cartridge-derived microbiota. More importantly, random 172 forest models generated using bacterial abundances from FIT cartridge-derived and 173 stool-derived DNA were equally predictive for differentiating healthy patients from those 174 with adenomas and carcinomas. possible that because the biomass contained in the FIT cartridges is considerably lower 182 than that in stool, the analysis was more sensitive to contaminants in our reagents or 183 the FIT cartridge [20] . Alternatively, storage conditions could have played a role in 184 biasing the relative abundances of certain genera. The feces in the FIT cartridges spent 185 more time exposed to ambient temperatures in order to be analyzed for hemoglobin 186 concentration. Therefore it is possible that certain bacterial populations, especially 187 aerobes, were able to grow. Considering Pantoea is rarely found in human feces and is 188 more commonly found in soil, plant surfaces, and air we suspect that it was a 189 contaminant. Regardless of the source of this and the other suspicious populations, any 190 biases were limited since the random forest feature selection process did not select 191 these populations and did not affect the ability to detect CRC from FIT cartridge-derived 192 
DNA. 193
Conclusions
